See more : Impact Minerals Limited (IPT.AX) Income Statement Analysis – Financial Results
Complete financial analysis of iROC Co., Ltd. (3555.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of iROC Co., Ltd., a leading company in the Semiconductors industry within the Technology sector.
- Leeds Group plc (LDSG.L) Income Statement Analysis – Financial Results
- Jiangsu Alcha Aluminium Group Co., Ltd. (002160.SZ) Income Statement Analysis – Financial Results
- Jiangxi Ganyue Expressway CO.,LTD. (600269.SS) Income Statement Analysis – Financial Results
- Supreme Petrochem Limited (SUPPETRO.NS) Income Statement Analysis – Financial Results
- Strategic Metals Ltd. (SMDZF) Income Statement Analysis – Financial Results
iROC Co., Ltd. (3555.TWO)
About iROC Co., Ltd.
iROC Co., Ltd. engages in the research and development, and sale of natural products in Japan. The company offers drinking water under the VACHI; skin care products under the QINGSKIN; and chicken essence under the DDDrops brand names, as well as DEDrops ginseng tonic drinks. It serves customers through online shops and distributors. The company was formerly known as Skymedi Corporation. The company was founded in 2003 and is based in New Taipei City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 65.41M | 23.23M | 18.75M | 152.06M | 164.03M |
| Cost of Revenue | 50.14M | 15.92M | 14.87M | 143.51M | 197.91M |
| Gross Profit | 15.28M | 7.31M | 3.88M | 8.55M | -33.88M |
| Gross Profit Ratio | 23.36% | 31.48% | 20.68% | 5.62% | -20.66% |
| Research & Development | 3.93M | 0.00 | 0.00 | 78.00K | 4.79M |
| General & Administrative | 22.36M | 20.27M | 22.81M | 21.48M | 21.38M |
| Selling & Marketing | 10.18M | 19.49M | 18.66M | 19.34M | 25.77M |
| SG&A | 32.54M | 39.76M | 41.47M | 40.83M | 48.21M |
| Other Expenses | 0.00 | -76.54M | 3.09M | -24.48M | 0.00 |
| Operating Expenses | 36.47M | 39.76M | 41.47M | 40.91M | 53.00M |
| Cost & Expenses | 86.60M | 55.68M | 56.34M | 184.42M | 250.92M |
| Interest Income | 361.00K | 1.14M | 1.37M | 1.39M | 95.00K |
| Interest Expense | 2.79M | 1.42M | 1.11M | 1.03M | 689.00K |
| Depreciation & Amortization | 1.24M | 881.00K | 2.32M | 2.38M | 398.00K |
| EBITDA | -14.93M | -106.97M | 31.15M | -52.01M | -57.77M |
| EBITDA Ratio | -22.82% | -460.47% | -163.68% | -34.90% | -52.73% |
| Operating Income | -21.19M | -107.85M | -33.00M | -55.45M | -86.89M |
| Operating Income Ratio | -32.39% | -464.26% | -176.05% | -36.47% | -52.97% |
| Total Other Income/Expenses | 2.05M | -76.83M | 65.32M | -23.06M | 24.88M |
| Income Before Tax | -19.14M | -109.28M | 27.73M | -55.42M | -62.00M |
| Income Before Tax Ratio | -29.26% | -470.38% | 147.89% | -36.44% | -37.80% |
| Income Tax Expense | -789.00K | 808.00K | 3.68M | 7.99M | 9.38M |
| Net Income | -18.33M | -110.08M | 24.04M | -63.40M | -52.63M |
| Net Income Ratio | -28.02% | -473.86% | 128.24% | -41.70% | -32.08% |
| EPS | -0.71 | -4.27 | 0.93 | -2.46 | -2.04 |
| EPS Diluted | -0.71 | -4.27 | 0.93 | -2.46 | -2.04 |
| Weighted Avg Shares Out | 25.76M | 25.76M | 25.76M | 25.76M | 25.76M |
| Weighted Avg Shares Out (Dil) | 25.76M | 25.76M | 25.81M | 25.76M | 25.76M |
Source: https://incomestatements.info
Category: Stock Reports